Developer docs
API playgroundTry for free, no card

Search company profiles

National Institute of Neurological Disorders and Stroke

Full company profile

uuid00068uf

Namestring
National Institute of Neurological Disorders and Stroke
Legal namestring
National Institute of Neurological Disorders and Stroke
Websiteurl
ninds.nih.gov
Company typeenum
Public
Founded yearint
1950
Descriptiontext

The National Institute of Neurological Disorders and Stroke (NINDS) is a U.S. federal government research institute established in 1950 and operating as a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. Headquartered in Bethesda, Maryland, with 101–250 employees, NINDS is the nation's primary federal funder and coordinator of biomedical research on the brain and nervous system, covering more than 131 neurological disorders including stroke, epilepsy, Parkinson's disease, ALS, and multiple sclerosis. Its intramural and extramural programs fund investigator-initiated research, training, and clinical trials, while its information products serve patients, caregivers, clinicians, and the general public.

NINDS's core "products" are clinical and educational assets rather than commercial goods: the NIH Stroke Scale (a standardized 11-category clinical assessment tool used globally to measure stroke severity), the Migraine Trainer mobile application (iOS and Android), the Know Stroke and Mind Your Risks public education campaigns, the Building Up the Nerve podcast for neuroscience trainees, and a free publications catalog of disorder-specific health information. Its technology stack is purpose-built for public dissemination and clinical standardization rather than software commercialization.

NINDS does not operate a commercial revenue model. It does not sell products or services; its activities are funded entirely through federal congressional appropriations channeled via NIH, and its resources are provided free of charge. Pricing is not applicable. As a public entity under the U.S. government, it has no private shareholders, no funding rounds, and no M&A activity. Current leadership is transitional following the 2025 removal of longtime Director Dr. Walter Koroshetz, with Amy Bany Adams, Ph.D. serving as Acting Director.

Short descriptiontext

NINDS is a U.S. federal research institute within NIH that funds and conducts biomedical research on more than 131 neurological disorders and stroke, providing free clinical tools, public education campaigns, and training resources to patients, clinicians, researchers, and the general public.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBethesda, United States
HQ citystring
Bethesda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
neurological research funding, stroke public education, clinical assessment tools, biomedical research grants, brain health information
Industry1 code
1Stroke & Vascular Neurology
CodeHLAKAIAGPrimaryYes
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Government Health Research
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Know Stroke
Description

Public education campaign focused on stroke awareness, prevention, signs and symptoms, and recovery

ninds.nih.gov:443
+3 more records
Core offering1 text field

NINDS is a U.S. federal research institute within the National Institutes of Health that funds and conducts biomedical research on neurological disorders and stroke. It provides free public health information, develops clinical assessment tools such as the NIH Stroke Scale, distributes research grants and training programs, and runs public education campaigns like Know Stroke and Mind Your Risks.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The National Institute of Neurological Disorders and Stroke (NINDS) is a federal research institute within NIH that advances brain and nervous system research. Rather than offering a commercial product platform, NINDS provides public health information resources, clinical assessment tools, educational programs, and mobile applications. The core offerings include the NIH Stroke Scale (a standardized clinical assessment tool), the Migraine Trainer® mobile app, the Know Stroke public education campaign, and the Building Up the Nerve podcast for neuroscience researchers. These resources collectively serve patients, caregivers, healthcare professionals, and researchers.

Product and service1 record
1NIH Stroke Scale
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A sister NIH institute focused on mental health research, with overlapping neuroscience funding, training programs, and clinical research infrastructure. Operates under the same federal appropriations process and faces similar political and administrative dynamics as NINDS.

TypeDirect peer
Description

An NIH institute focused on aging research, with substantial overlap in neurodegenerative disease research (Alzheimer's, dementia) that intersects directly with NINDS's portfolio. Shares the same congressional funding mechanism and grant infrastructure.

TypeBroad incumbent
Description

The largest NIH institute and a peer in scale, mission, and structure. NCI operates a similar federal research funding model, runs clinical trials, and maintains public education campaigns — making it structurally comparable despite differing disease focus.

TypeDirect peer
Description

A sister NIH institute that funds and conducts research on child health, including pediatric neurological disorders. Shares NINDS's intramural/extramural research structure and federal funding model.

TypeBroad incumbent
Description

A large nonprofit that funds stroke and cardiovascular research and runs the Get With The Guidelines stroke program. Comparable as a major non-federal funder of stroke research and public education campaigns, directly relevant to NINDS's stroke portfolio.

TypeBroad incumbent
Description

The largest nonprofit funder of Alzheimer's and dementia research, with overlapping disease portfolio (cognitive decline, neurodegeneration) with NINDS. Operates a comparable combination of research funding, public education, and advocacy.

TypeEmerging player
Description

A disease-focused nonprofit that funds epilepsy research and was one of the 113 organizations that publicly opposed NINDS leadership changes. Directly comparable as a stakeholder in NINDS-funded research areas and a co-convener of patient advocacy.

TypeOthers
Description

A professional society of neurologists that issues clinical guidelines and provides continuing medical education. Directly comparable as a stakeholder that disseminates NINDS-developed clinical tools (like the NIH Stroke Scale) to practicing neurologists.

TypeDirect peer
Description

A sister NIH institute that operates a comparable model of intramural/extramural research funding, public health campaigns, and clinical trials (including those led by NINDS Clinical Director Dr. Avindra Nath). Comparable in scale and operating structure.

TypeBroad incumbent
Description

A federal public health agency that conducts surveillance, runs public education campaigns (including on stroke and brain health), and provides clinical guidance. Comparable as a federal entity that produces complementary public health resources to NINDS.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment66 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Institute of Neurological Disorders and Stroke

Government Health Researchninds.nih.gov

NINDS is a U.S. federal research institute within NIH that funds and conducts biomedical research on more than 131 neurological disorders and stroke, providing free clinical tools, public education campaigns, and training resources to patients, clinicians, researchers, and the general public.

What National Institute of Neurological Disorders and Stroke does

The National Institute of Neurological Disorders and Stroke (NINDS) is a U.S. federal government research institute established in 1950 and operating as a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. Headquartered in Bethesda, Maryland, with 101–250 employees, NINDS is the nation's primary federal funder and coordinator of biomedical research on the brain and nervous system, covering more than 131 neurological disorders including stroke, epilepsy, Parkinson's disease, ALS, and multiple sclerosis. Its intramural and extramural programs fund investigator-initiated research, training, and clinical trials, while its information products serve patients, caregivers, clinicians, and the general public.

NINDS's core "products" are clinical and educational assets rather than commercial goods: the NIH Stroke Scale (a standardized 11-category clinical assessment tool used globally to measure stroke severity), the Migraine Trainer mobile application (iOS and Android), the Know Stroke and Mind Your Risks public education campaigns, the Building Up the Nerve podcast for neuroscience trainees, and a free publications catalog of disorder-specific health information. Its technology stack is purpose-built for public dissemination and clinical standardization rather than software commercialization.

NINDS does not operate a commercial revenue model. It does not sell products or services; its activities are funded entirely through federal congressional appropriations channeled via NIH, and its resources are provided free of charge. Pricing is not applicable. As a public entity under the U.S. government, it has no private shareholders, no funding rounds, and no M&A activity. Current leadership is transitional following the 2025 removal of longtime Director Dr. Walter Koroshetz, with Amy Bany Adams, Ph.D. serving as Acting Director.

National Institute of Neurological Disorders and Stroke firmographics

Firmographics
Name
National Institute of Neurological Disorders and Stroke
Legal name
National Institute of Neurological Disorders and Stroke
Website
https://ninds.nih.gov
Company type
Public
Founded year
1950
Operating status
Operating
Headcount range
101–250 employees
Short description
NINDS is a U.S. federal research institute within NIH that funds and conducts biomedical research on more than 131 neurological disorders and stroke, providing free clinical tools, public education campaigns, and training resources to patients, clinicians, researchers, and the general public.
Ownership category
akta.pro rank

National Institute of Neurological Disorders and Stroke industry classification

Industry
Product category
Government Health Research
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Stroke & Vascular Neurology (HLAKAIAG)

Keywords

  • Neurological research funding
  • Stroke public education
  • Clinical assessment tools
  • Biomedical research grants
  • Brain health information

Where National Institute of Neurological Disorders and Stroke is headquartered

Location

Headquarters

HQ city
Bethesda
HQ country
United States
HQ region
North America

Markets served

National Institute of Neurological Disorders and Stroke business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Others

Distribution channels3 records

Marketing channels7 records

National Institute of Neurological Disorders and Stroke product offering

Product offering

Core offering

NINDS is a U.S. federal research institute within the National Institutes of Health that funds and conducts biomedical research on neurological disorders and stroke. It provides free public health information, develops clinical assessment tools such as the NIH Stroke Scale, distributes research grants and training programs, and runs public education campaigns like Know Stroke and Mind Your Risks.

Product overview

The National Institute of Neurological Disorders and Stroke (NINDS) is a federal research institute within NIH that advances brain and nervous system research. Rather than offering a commercial product platform, NINDS provides public health information resources, clinical assessment tools, educational programs, and mobile applications. The core offerings include the NIH Stroke Scale (a standardized clinical assessment tool), the Migraine Trainer® mobile app, the Know Stroke public education campaign, and the Building Up the Nerve podcast for neuroscience researchers. These resources collectively serve patients, caregivers, healthcare professionals, and researchers.

Differentiator

Problem solved

Functional benefit

Brands

  • Know Stroke: Public education campaign focused on stroke awareness, prevention, signs and symptoms, and recovery
  • Migraine Trainer
  • Mind Your Risks
  • Building Up the Nerve

Products and services

  • NIH Stroke Scale

Companies that use National Institute of Neurological Disorders and Stroke

Customer profile

Segments4 records

Ideal customer profiles1 record

National Institute of Neurological Disorders and Stroke technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

National Institute of Neurological Disorders and Stroke partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

National Institute of Neurological Disorders and Stroke competitors and assessment

Company assessment

Direct peers

  • National Institute of Mental Health (NIMH): A sister NIH institute focused on mental health research, with overlapping neuroscience funding, training programs, and clinical research infrastructure. Operates under the same federal appropriations process and faces similar political and administrative dynamics as NINDS.
  • National Institute on Aging (NIA): An NIH institute focused on aging research, with substantial overlap in neurodegenerative disease research (Alzheimer's, dementia) that intersects directly with NINDS's portfolio. Shares the same congressional funding mechanism and grant infrastructure.
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): A sister NIH institute that funds and conducts research on child health, including pediatric neurological disorders. Shares NINDS's intramural/extramural research structure and federal funding model.
  • National Institute of Allergy and Infectious Diseases (NIAID): A sister NIH institute that operates a comparable model of intramural/extramural research funding, public health campaigns, and clinical trials (including those led by NINDS Clinical Director Dr. Avindra Nath). Comparable in scale and operating structure.

Broad incumbents

  • National Cancer Institute (NCI): The largest NIH institute and a peer in scale, mission, and structure. NCI operates a similar federal research funding model, runs clinical trials, and maintains public education campaigns — making it structurally comparable despite differing disease focus.
  • American Heart Association / American Stroke Association: A large nonprofit that funds stroke and cardiovascular research and runs the Get With The Guidelines stroke program. Comparable as a major non-federal funder of stroke research and public education campaigns, directly relevant to NINDS's stroke portfolio.
  • Alzheimer's Association: The largest nonprofit funder of Alzheimer's and dementia research, with overlapping disease portfolio (cognitive decline, neurodegeneration) with NINDS. Operates a comparable combination of research funding, public education, and advocacy.
  • Centers for Disease Control and Prevention (CDC): A federal public health agency that conducts surveillance, runs public education campaigns (including on stroke and brain health), and provides clinical guidance. Comparable as a federal entity that produces complementary public health resources to NINDS.

Emerging players

  • Epilepsy Foundation: A disease-focused nonprofit that funds epilepsy research and was one of the 113 organizations that publicly opposed NINDS leadership changes. Directly comparable as a stakeholder in NINDS-funded research areas and a co-convener of patient advocacy.

Others

  • American Academy of Neurology (AAN): A professional society of neurologists that issues clinical guidelines and provides continuing medical education. Directly comparable as a stakeholder that disseminates NINDS-developed clinical tools (like the NIH Stroke Scale) to practicing neurologists.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

National Institute of Neurological Disorders and Stroke social profiles

Digital presence

National Institute of Neurological Disorders and Stroke financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Institute of Neurological Disorders and Stroke leadership team

Management profile

Number of profiles

Profiles2 records

National Institute of Neurological Disorders and Stroke funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Institute of Neurological Disorders and Stroke M&A and investment

M&A and investment

M&A

Investments66 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute of Neurological Disorders and Stroke

What does National Institute of Neurological Disorders and Stroke do?

NINDS is a U.S. federal research institute within the National Institutes of Health that funds and conducts biomedical research on neurological disorders and stroke. It provides free public health information, develops clinical assessment tools such as the NIH Stroke Scale, distributes research grants and training programs, and runs public education campaigns like Know Stroke and Mind Your Risks.

Is National Institute of Neurological Disorders and Stroke a public or private company?

National Institute of Neurological Disorders and Stroke is a public company. It is classified as state government owned and is currently operating.

When was National Institute of Neurological Disorders and Stroke founded?

National Institute of Neurological Disorders and Stroke was founded in 1950. It employs 101 to 250 people.

Where is National Institute of Neurological Disorders and Stroke based?

National Institute of Neurological Disorders and Stroke is headquartered in Bethesda, United States, in the North America region.

Who are National Institute of Neurological Disorders and Stroke's main competitors?

Direct peers on record are National Institute of Mental Health (NIMH), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Institute of Allergy and Infectious Diseases (NIAID). Broad incumbents are National Cancer Institute (NCI), American Heart Association / American Stroke Association, Alzheimer's Association and Centers for Disease Control and Prevention (CDC). Epilepsy Foundation is listed as an emerging player. American Academy of Neurology (AAN) is listed as an others.

Does National Institute of Neurological Disorders and Stroke have an API?

No public API is recorded for National Institute of Neurological Disorders and Stroke.

What industry is National Institute of Neurological Disorders and Stroke in?

National Institute of Neurological Disorders and Stroke's product category is Government Health Research. Its primary akta.pro industry code is HLAKAIAG, Stroke & Vascular Neurology. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireOpsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic PainOpsin Biotherapeutics received a $2.35 million Phase II NIH grant from NINDS to advance optogenetic neuromodulation for chronic pain. The non-viral platform uses gold nanorods and light to deliver DNA to pain-blocking neurons, aiming to replace electrical spinal cord stimulation. The funding follows successful Phase I milestones and supports IND-enabling development.AllsciMIT spinout Artificial Axon gets NINDS backing for MS lesion-mimicking drug screening platformMIT spinout Artificial Axon Labs has secured a USD 1.48 million grant from the National Institute of Neurological Disorders and Stroke to advance its 3D-printed biomimetic drug screening platform for multiple sclerosis. The funding supports the development of an assay that replicates the inflammatory microenvironment of active lesions to better identify remyelinating therapies, addressing a significant gap in current drug development tools.PR NewswirePhoenix Nest Awarded Prestigious Small Business Innovation Research (SBIR) Grant of $2,984,658Phoenix Nest received a $2,984,658 SBIR grant to manufacture clinical-grade AAV9 gene therapy JLK-247 for Sanfilippo syndrome type C patients. The therapy is the first potential cure for this rare fatal childhood disease, and the company has obtained orphan drug and rare pediatric disease designations from the FDA.BloombergHow Covid Quietly Rewires the BrainIn spring 2020, Dr. Avindra Nath and his team at the National Institute of Neurological Disorders and Stroke were called upon to investigate several unexplained sudden deaths in New York City, where victims stopped breathing during sleep with no lung or heart damage. SARS-CoV-2 was detected in the victims' lung tissue, but this did not account for the respiratory failure, prompting further examination of brain tissue in Maryland. The investigation explored whether COVID-19 could cause Ondine's curse, a rare condition typically seen in infants with genetic mutations or adults after severe trauma, raising questions about the virus's potential neurological effects.PR Newswire113 Epilepsy Organizations Unite to Express Concerns about Leadership Change at the National Institute of Neurological Disorders and Stroke113 epilepsy organizations issued a joint statement expressing significant concern over the NIH's denial of Dr. Walter Koroshetz's reappointment as Director of the National Institute of Neurological Disorders and Stroke (NINDS). The organizations warn that this leadership change threatens urgently needed epilepsy and neurological research at a time when 14 of NIH's 27 Institutes and Centers lack permanent leadership. Epilepsy affects approximately 3.4 million Americans and imposes an estimated annual economic burden of $54 billion on the U.S. healthcare system.FierceBiotechNIH instability grows with exit of neuro director, leaving half of institutes under interim leadershipWalter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS), is departing the NIH with his last day expected Jan. 24, after the agency rebuffed a request to reappoint him, leaving 14 of NIH's 27 units under interim leadership. The American Academy of Neurology has voiced significant concern over the abrupt decision, citing the lack of consultation with key neurology stakeholders and the absence of a clear succession plan. This departure is part of broader leadership instability at NIH, FDA, and other HHS agencies following policy changes implemented during the Trump administration, with industry groups warning that ongoing volatility threatens U.S. leadership in biotechnology.STATDirector of NIH neurological disorders institute is ousted, adding to leadership churnWalter Koroshetz, director of the National Institute of Neurological Disorders and Stroke (NINDS), will soon leave his role after a request to reappoint him was denied. His departure means approximately half of the 27 NIH divisions will now have interim leaders, signaling significant leadership churn within the agency. Koroshetz indicated in an email to staff that a short-term extension remains possible but is unlikely.University of Maryland2025 ArchiveDr. J. Marc Simard from the University of Maryland School of Medicine received the Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for his pioneering research on brain injuries. The award provides $4.34 million in funding for his research, which focuses on the SUR1-TRMP4 channel and aims to develop pharmacological interventions for stroke and traumatic brain injuries. This research is expected to advance the understanding and treatment of cerebral edema through ongoing clinical trials.SBIR.govTopicThe National Institute of Neurological Disorders and Stroke (NINDS) has closed a funding solicitation for SBIR Phase II grants supporting clinical trials in neurological diseases. The program aims to bridge the funding gap between early-stage research and commercialization by providing financial support for exploratory clinical studies of therapeutics, devices, and diagnostics. Eligible applicants must be small business concerns with previously funded NIH SBIR or STTR projects seeking to advance their technologies toward market entry.Mpo-magNIH Grant Awarded to Feinstein Institutes for Vagus Nerve Stimulation TechThe Feinstein Institutes for Medical Research has received a $3 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, in collaboration with imec, to develop more precise vagus nerve stimulation technology. Led by Dr. Stavros Zanos, the research will utilize imec's specialized interferential stimulation devices and prior vagus nerve mapping to target specific fibers, potentially improving treatments for inflammatory conditions such as rheumatoid arthritis, heart failure, and inflammatory bowel disease. The five-year project builds on two years of NIH SPARC-funded anatomical mapping of the vagus nerve.